Hims & Hers Health Inc (NYSE:HIMS) shares traded -5.39% lower at $30.87 on Wall Street last session.
HIMS stock price is now 29.53% away from the 50-day moving average and 65.63% away from the 200-day moving average. The market capitalization of the company currently stands at $6.74B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On August 22, 2024, Needham recently initiated its ‘Buy’ rating on the stock quoting a target price of $24, while ‘Imperial Capital’ rates the stock as ‘In-line’
In other news, Melissa Baird, Officer bought 85,561 shares of the company’s stock on Dec 10 ’24. The stock was bought for $2,641,268 at an average price of $30.87. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 10 ’24, Officer Chi Michael bought 7,259 shares of the business’s stock. A total of $234,103 was incurred on buying the stock at an average price of $32.25. A total of 18.85% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $8.09 and a high of $35.02. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82. The fifty day moving average price for HIMS is $23.5826 and a two-hundred day moving average price translates $18.53515 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-09-30. The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent. For the current quarter, analysts expect HIMS to generate $469.67M in revenue.
